Age, Biography and Wiki
Jian Liu (academic) was born on 20 December, 1962 in North Carolina, is a Professor. Discover Jian Liu (academic)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 61 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
61 years old |
Zodiac Sign |
Sagittarius |
Born |
20 December, 1962 |
Birthday |
20 December |
Birthplace |
N/A |
Nationality |
United States |
We recommend you to check the complete list of Famous People born on 20 December.
He is a member of famous Professor with the age 61 years old group.
Jian Liu (academic) Height, Weight & Measurements
At 61 years old, Jian Liu (academic) height not available right now. We will update Jian Liu (academic)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Jian Liu (academic) Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Jian Liu (academic) worth at the age of 61 years old? Jian Liu (academic)’s income source is mostly from being a successful Professor. He is from United States. We have estimated
Jian Liu (academic)'s net worth
, money, salary, income, and assets.
Net Worth in 2023 |
$1 Million - $5 Million |
Salary in 2023 |
Under Review |
Net Worth in 2022 |
Pending |
Salary in 2022 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
Professor |
Jian Liu (academic) Social Network
Instagram |
|
Linkedin |
|
Twitter |
|
Facebook |
|
Wikipedia |
|
Imdb |
|
Timeline
Jian Liu started his independent scientific career as an assistant professor in chemical biology and medicinal chemistry at the University of North Carolina in 2000 and moved to the rank of full professor in 2012. His research interest is in the interface of chemistry and biology of heparin and heparan sulfate. His work covers the understanding of the biosynthetic mechanism of heparan sulfate biosynthesis and the development of heparan sulfate-based medicines. In his work at the Massachusetts Institute of Technology and the early period of his independent career at the University of North Carolina, he isolated the heparan sulfate 3-O-sulfotransferases that are key enzymes responsible for the biosynthesis of heparan sulfate with anticoagulant activity. He then led a research team to discover a chemoenzymatic method to prepare synthetic heparin, a drug to treat blood clotting disorders. He is also engaged in discovering new therapeutic potential of heparan sulfate and chondroitin sulfate through exploiting the anti-inflammatory effects of these molecules. His research team recently announced that a synthetic heparan sulfate 18-mer protects against acute liver injury caused by acetaminophen overdose. The team also discovered that a synthetic chondroitin sulfate E 19-mer attenuates multi-organ damage in endotoxemia mice. Jian Liu also participated in the effort organized by the US FDA and US Pharmacopeia to define the purity standards for heparin drugs. He served as a member of Unfractionated Heparins Ad Hoc Advisory Panel for US Pharmacopeia from 2010 to 2012.
Jian Liu received his bachelor degree in chemistry and master degree in biochemistry from Nankai University. He then moved to the University of Iowa in 1988 to obtain his PhD training in medicinal chemistry. After his PhD studies, he joined the Massachusetts Institute of Technology as a postdoctoral fellow in 1993.
Jian Liu (born December 20, 1962) is a John & Deborah S. McNeill, Jr. Distinguished Professor at the UNC Eshelman School of Pharmacy, at the University of North Carolina at Chapel Hill. He is also a founder and the chief scientific officer at Glycan Therapeutics.